In this context, E-proteins act as tumor suppressors, as several groups have shown that E2a-deficient mice develop T-cell lymphoma and that this deficiency accelerates leukemia onset and progression in Tal1-transgenic mice (10, 106). The gene discussed is TAL1; the disease is neoplasm.